AR108778A1 - Compuestos antibacterianos - Google Patents
Compuestos antibacterianosInfo
- Publication number
- AR108778A1 AR108778A1 ARP170101555A ARP170101555A AR108778A1 AR 108778 A1 AR108778 A1 AR 108778A1 AR P170101555 A ARP170101555 A AR P170101555A AR P170101555 A ARP170101555 A AR P170101555A AR 108778 A1 AR108778 A1 AR 108778A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- alkylenyl
- atom
- alkyl
- optionally substituted
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 9
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 8
- 125000005466 alkylenyl group Chemical group 0.000 abstract 8
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 5
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 5
- 125000004429 atom Chemical group 0.000 abstract 4
- 125000005843 halogen group Chemical group 0.000 abstract 4
- 229910052757 nitrogen Inorganic materials 0.000 abstract 4
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 4
- 125000001424 substituent group Chemical group 0.000 abstract 4
- 125000001931 aliphatic group Chemical group 0.000 abstract 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 3
- 125000004043 oxo group Chemical group O=* 0.000 abstract 3
- 125000006274 (C1-C3)alkoxy group Chemical group 0.000 abstract 2
- 125000004122 cyclic group Chemical group 0.000 abstract 2
- 125000005842 heteroatom Chemical group 0.000 abstract 2
- 125000004193 piperazinyl group Chemical group 0.000 abstract 2
- 125000003386 piperidinyl group Chemical group 0.000 abstract 2
- 125000006583 (C1-C3) haloalkyl group Chemical group 0.000 abstract 1
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 150000001204 N-oxides Chemical class 0.000 abstract 1
- 125000003368 amide group Chemical group 0.000 abstract 1
- 125000006615 aromatic heterocyclic group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- -1 azabicyclo-octyl Chemical group 0.000 abstract 1
- 125000002393 azetidinyl group Chemical group 0.000 abstract 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical group O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 150000007522 mineralic acids Chemical class 0.000 abstract 1
- 125000002757 morpholinyl group Chemical group 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000000719 pyrrolidinyl group Chemical group 0.000 abstract 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/052—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cephalosporin Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
Reivindicación 1: Un compuesto de fórmula (1): A-L¹-Y-L²-R-B (1) en la que A es un grupo cíclico que tiene una de las fórmulas (2), (3) y (4), en las que G¹ es CH o N; G² es CR¹ o N; G³ es CH o N cuando la línea discontinua representa un doble enlace, o CH₂, NH u O cuando la línea discontinua representa un enlace sencillo; G⁴ es CH o N cuando la línea discontinua representa un doble enlace, o CH₂, NH u O cuando la línea discontinua representa un enlace sencillo; C¹ representa los átomos necesarios para formar un ciclo alifático o aromático de seis miembros que comprende opcionalmente uno o más heteroátomos seleccionados de átomo de nitrógeno y átomo de oxígeno, estando dicho ciclo opcionalmente sustituido con uno o más sustituyentes seleccionados del grupo que consiste en átomo de halógeno, grupo alquilo C₁₋₃, grupo ciano, grupo oxo (=O), y grupo alcoxi C₁₋₃; R¹ es átomo de hidrógeno, átomo de halógeno, grupo ciano o alcoxi C₁₋₃; L¹ es un enlace s, o grupo alquilenilo C₁₋₃, opcionalmente sustituido con grupo hidroxi; Y es un anillo seleccionado del grupo que consiste en un anillo de piperidinilo, piperazinilo, pirrolidinilo, 1-3 ciclobutilo, 1-3 ciclopentilo, 1-2 ciclopropilo, azetidinilo, azabiciclo-octilo, morfolinilo y ciclohexilo, estando dicho anillo opcionalmente sustituido con uno o más sustituyentes seleccionados del grupo que consiste en grupo hidroxi, grupo alquilenil C₁₋₃-OH, grupo alquilenil C₁₋₃-O-alquilo C₁₋₃, grupo alquilenil C₁₋₃-CONRR, y grupo CONRR, en los que R y R son átomo de hidrógeno o alquilo C₁₋₃; L² es un enlace s, grupo -alquilenilo C₁₋₃-, grupo NR, grupo NR-alquilenilo C₁₋₃, grupo alquilenil C₁₋₃-NR, grupo NR-alquilenil C₁₋₃-NR, o grupo alquilenil C₁₋₃-NR-alquilenilo C₁₋₃, estando dicho grupo opcionalmente sustituido con un grupo hidroxi, en los que R es hidrógeno, alquilo C₁₋₃, alquilenil C₁₋₃-OH, alquilenil C₁₋₃-O-alquilo C₁₋₃, o alquilenil C₁₋₃-CONRR, en el que R y R son un átomo de hidrógeno o alquilo C₁₋₃; R es un enlace s o un anillo heterocíclico, alifático o aromático, que tiene 5 miembros, que contiene uno o más átomo de nitrógeno, opcionalmente sustituido con CH₂OH, CH₂CN, CN o CONRR, en el que R y R son un átomo de hidrógeno o alquilo C₁₋₃; y B es un grupo cíclico que tiene una de las fórmulas (5) a (10), en las que G⁵ es CH o N; G⁶ es CH o N; G⁷ es CH o N; G⁸ es O ó NR⁶; R² es un átomo de hidrógeno o un átomo de halógeno; R³ es un átomo de hidrógeno o un grupo ciano, con la condición de que, cuando R³ es un grupo ciano, A es diferente de la fórmula (4); R⁴ y R⁵ son átomos de hidrógeno; R⁶ es un átomo de hidrógeno o un grupo alquilo C₁₋₃; C² representa los átomos necesarios para formar un heterociclo alifático o aromático de seis miembros que comprende un átomo de oxígeno o un átomo de nitrógeno; C³ representa los átomos necesarios para formar un heterociclo alifático de seis miembros que comprende un átomo de oxígeno y opcionalmente un átomo de nitrógeno, estando dicho heterociclo opcionalmente sustituido con uno o más sustituyentes seleccionados del grupo que consiste en grupo haloalquilo C₁₋₃, grupo amido (-CONH₂), y grupo oxo (=O); y C⁴ representa los átomos necesarios para formar un biciclo condensado de diez miembros que comprende al menos un átomo de nitrógeno y al menos otro heteroátomo seleccionado de átomo de oxígeno y átomo de azufre, estando dicho biciclo opcionalmente sustituido con uno o más sustituyentes seleccionados del grupo que consiste en átomo de halógeno, grupo alquilo C₁₋₃, grupo ciano, y grupo oxo (=O); con la condición de que cuando Y es un anillo de piperidinilo o un anillo de piperazinilo, si A está representado por la fórmula (2) y B está representado por la fórmula (6) ó (7), entonces G² es solamente N; y sales de adición con ácidos o bases orgánicos o inorgánicos farmacéuticamente aceptables, enantiómeros, N-óxidos y sales de amonio cuaternario de dicho compuesto de fórmula (1).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16173550 | 2016-06-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR108778A1 true AR108778A1 (es) | 2018-09-26 |
Family
ID=56116327
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170101554A AR108777A1 (es) | 2016-06-08 | 2017-06-07 | Compuestos antibacterianos |
| ARP170101555A AR108778A1 (es) | 2016-06-08 | 2017-06-07 | Compuestos antibacterianos |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP170101554A AR108777A1 (es) | 2016-06-08 | 2017-06-07 | Compuestos antibacterianos |
Country Status (28)
| Country | Link |
|---|---|
| US (2) | US10640488B2 (es) |
| EP (2) | EP3468975B1 (es) |
| JP (2) | JP2019517546A (es) |
| KR (2) | KR20190019084A (es) |
| CN (2) | CN109790157A (es) |
| AR (2) | AR108777A1 (es) |
| AU (2) | AU2017276627A1 (es) |
| BR (2) | BR112018075297A2 (es) |
| CA (2) | CA3025270A1 (es) |
| CY (1) | CY1123194T1 (es) |
| DK (1) | DK3468975T3 (es) |
| EA (2) | EA201892822A1 (es) |
| ES (1) | ES2802233T3 (es) |
| HR (1) | HRP20200894T1 (es) |
| HU (1) | HUE049547T2 (es) |
| IL (2) | IL263285A (es) |
| LT (1) | LT3468975T (es) |
| MA (1) | MA45221A (es) |
| MD (1) | MD3468975T2 (es) |
| ME (1) | ME03738B (es) |
| MX (2) | MX2018015125A (es) |
| PL (1) | PL3468975T3 (es) |
| PT (1) | PT3468975T (es) |
| RS (1) | RS60511B1 (es) |
| SG (2) | SG11201810389XA (es) |
| SI (1) | SI3468975T1 (es) |
| SM (1) | SMT202000335T1 (es) |
| WO (2) | WO2017211759A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL3468975T3 (pl) * | 2016-06-08 | 2020-09-07 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Nowe związki przeciwbakteryjne |
| US12446578B2 (en) | 2020-02-10 | 2025-10-21 | Virox Technologies Inc. | Antimicrobial compositions containing peroxyphthalic acid and/or salt thereof |
| EP4247387A1 (en) | 2020-11-23 | 2023-09-27 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| WO2022235605A1 (en) | 2021-05-04 | 2022-11-10 | Enanta Pharmaceuticals, Inc. | Novel macrocyclic antiviral agents |
| CN113698412A (zh) * | 2021-09-01 | 2021-11-26 | 临沂大学 | 一种香豆素并[4,3-b]吡咯类衍生物及其合成方法和应用 |
| WO2023086350A1 (en) | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Alkyne-containing antiviral agents |
| WO2023086400A1 (en) | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| WO2023086352A1 (en) | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| WO2023107419A1 (en) | 2021-12-08 | 2023-06-15 | Enanta Pharmaceuticals, Inc. | Saturated spirocyclics as antiviral agents |
| WO2023137007A1 (en) * | 2022-01-11 | 2023-07-20 | Enanta Pharmaceuticals, Inc. | Processes for the preparation of 4,6,7-trifluoro-1h-indole-2-carboxylic acid |
| US12145942B2 (en) | 2022-04-05 | 2024-11-19 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| CN115850672B (zh) * | 2022-11-25 | 2024-07-19 | 浙江甬仑聚嘉新材料有限公司 | 一种液晶聚合物及其制备方法和应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2886570B2 (ja) | 1989-09-29 | 1999-04-26 | エーザイ株式会社 | 縮合ヘテロ環を有する化合物 |
| IL101722A (en) * | 1991-05-02 | 1996-05-14 | Wyeth John & Brother Ltd | Piperazine derivatives their preparation and pharmaceutical compositions containing them |
| US5607936A (en) | 1994-09-30 | 1997-03-04 | Merck & Co., Inc. | Substituted aryl piperazines as neurokinin antagonists |
| FR2822154B1 (fr) | 2001-03-13 | 2005-10-21 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent |
| MXPA04012440A (es) * | 2002-06-12 | 2005-04-28 | Abbott Lab | Antagonistas de receptor de hormona concentradora de melanina. |
| DE102004041163A1 (de) | 2004-08-25 | 2006-03-02 | Morphochem Aktiengesellschaft für kombinatorische Chemie | Neue Verbindungen mit antibakterieller Aktivität |
| WO2006046552A1 (ja) * | 2004-10-27 | 2006-05-04 | Toyama Chemical Co., Ltd. | 新規な含窒素複素環化合物およびその塩 |
| EP1863483A4 (en) | 2005-03-31 | 2010-03-31 | Janssen Pharmaceutica Nv | Bicyclic pyrazole compounds as anti-bacteriostatic agents |
| AU2006250987A1 (en) * | 2005-05-24 | 2006-11-30 | Astrazeneca Ab | Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| MY150958A (en) * | 2005-06-16 | 2014-03-31 | Astrazeneca Ab | Compounds for the treatment of multi-drug resistant bacterial infections |
| EP2468743A1 (en) * | 2005-06-24 | 2012-06-27 | Toyama Chemical Co., Ltd. | Nitrogen-containing bicyclic compounds useful as antibacterial agents |
| CN101346379A (zh) * | 2005-10-21 | 2009-01-14 | 葛兰素集团有限公司 | 用作抗菌剂的周环并合的三环化合物 |
| CA2685888A1 (en) | 2007-05-09 | 2008-11-20 | Pfizer Inc. | Substituted heterocyclic derivatives and their pharmaceutical use and compositions |
| JP5620636B2 (ja) * | 2007-11-26 | 2014-11-05 | 富山化学工業株式会社 | 新規な複素環化合物またはその塩を含有する抗菌剤 |
| US20110071155A1 (en) * | 2008-05-23 | 2011-03-24 | Carlos Alemparte-Gallardo | Tricyclic Nitrogen Containing Compounds And Their Use As Antibacterials |
| CN102105473B (zh) * | 2008-05-23 | 2013-05-08 | 葛兰素集团有限公司 | 三环含氮化合物及其作为抗菌剂的用途 |
| TW201022279A (en) * | 2008-11-14 | 2010-06-16 | Astrazeneca Ab | Chemical compounds |
| JP5653935B2 (ja) * | 2009-01-15 | 2015-01-14 | グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ | 抗菌薬として有用なナフチリジン―２（１ｈ）−オン化合物 |
| CN102361863B (zh) | 2009-01-21 | 2014-12-03 | 巴斯利尔药物股份公司 | 新的二环抗生素 |
| WO2012003418A2 (en) | 2010-07-02 | 2012-01-05 | The University Of North Carolina At Chapel Hill | Functionally selective ligands of dopamine d2 receptors |
| WO2012117421A1 (en) * | 2011-03-02 | 2012-09-07 | Orchid Research Laboratories Ltd | Histone deacetylase inhibitors |
| AU2012275499A1 (en) | 2011-06-27 | 2013-12-19 | Kyorin Pharmaceutical Co., Ltd. | Bridged bicyclic compounds for the treatment of bacterial infections |
| TWI594996B (zh) | 2011-11-08 | 2017-08-11 | 艾克泰聯製藥有限公司 | ２－氧代－唑烷－３，５－二基抗生素衍生物 |
| EP2785721A1 (en) | 2011-11-30 | 2014-10-08 | Actelion Pharmaceuticals Ltd. | 3,7-disubstituted octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one antibiotics |
| CN105218501A (zh) * | 2014-07-03 | 2016-01-06 | 南京大学 | 含哌嗪环的香豆素类衍生物及其制备与在抗菌药物中的应用 |
| AR101674A1 (es) | 2014-08-22 | 2017-01-04 | Glaxosmithkline Ip Dev Ltd | Uso de un compuesto tricíclico que contiene nitrógeno |
| MA41168A (fr) | 2014-12-17 | 2017-10-24 | Acraf | Nouveaux composés antibactériens |
| MA41169A (fr) * | 2014-12-17 | 2017-10-24 | Acraf | Composés antibactériens à large spectre d'activité |
| PL3468975T3 (pl) * | 2016-06-08 | 2020-09-07 | Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. | Nowe związki przeciwbakteryjne |
-
2017
- 2017-06-05 PL PL17732775T patent/PL3468975T3/pl unknown
- 2017-06-05 KR KR1020187036946A patent/KR20190019084A/ko not_active Ceased
- 2017-06-05 SI SI201730306T patent/SI3468975T1/sl unknown
- 2017-06-05 MD MDE20190471T patent/MD3468975T2/ro not_active IP Right Cessation
- 2017-06-05 WO PCT/EP2017/063600 patent/WO2017211759A1/en not_active Ceased
- 2017-06-05 MA MA045221A patent/MA45221A/fr unknown
- 2017-06-05 SM SM20200335T patent/SMT202000335T1/it unknown
- 2017-06-05 AU AU2017276627A patent/AU2017276627A1/en not_active Abandoned
- 2017-06-05 ME MEP-2020-112A patent/ME03738B/me unknown
- 2017-06-05 MX MX2018015125A patent/MX2018015125A/es unknown
- 2017-06-05 EA EA201892822A patent/EA201892822A1/ru unknown
- 2017-06-05 MX MX2018015126A patent/MX2018015126A/es unknown
- 2017-06-05 KR KR1020187036945A patent/KR20190019083A/ko not_active Ceased
- 2017-06-05 CN CN201780042649.1A patent/CN109790157A/zh active Pending
- 2017-06-05 JP JP2018564240A patent/JP2019517546A/ja active Pending
- 2017-06-05 US US16/307,193 patent/US10640488B2/en not_active Expired - Fee Related
- 2017-06-05 HR HRP20200894TT patent/HRP20200894T1/hr unknown
- 2017-06-05 US US16/307,410 patent/US10633366B2/en not_active Expired - Fee Related
- 2017-06-05 EP EP17732775.6A patent/EP3468975B1/en active Active
- 2017-06-05 SG SG11201810389XA patent/SG11201810389XA/en unknown
- 2017-06-05 ES ES17732775T patent/ES2802233T3/es active Active
- 2017-06-05 JP JP2018564236A patent/JP2019517545A/ja active Pending
- 2017-06-05 AU AU2017276626A patent/AU2017276626A1/en not_active Abandoned
- 2017-06-05 BR BR112018075297-5A patent/BR112018075297A2/pt not_active IP Right Cessation
- 2017-06-05 PT PT177327756T patent/PT3468975T/pt unknown
- 2017-06-05 LT LTEP17732775.6T patent/LT3468975T/lt unknown
- 2017-06-05 HU HUE17732775A patent/HUE049547T2/hu unknown
- 2017-06-05 DK DK17732775.6T patent/DK3468975T3/da active
- 2017-06-05 CA CA3025270A patent/CA3025270A1/en not_active Abandoned
- 2017-06-05 RS RS20200735A patent/RS60511B1/sr unknown
- 2017-06-05 SG SG11201810352XA patent/SG11201810352XA/en unknown
- 2017-06-05 EA EA201892815A patent/EA201892815A1/ru unknown
- 2017-06-05 WO PCT/EP2017/063601 patent/WO2017211760A1/en not_active Ceased
- 2017-06-05 CA CA3025624A patent/CA3025624A1/en not_active Abandoned
- 2017-06-05 CN CN201780039687.1A patent/CN109415373A/zh active Pending
- 2017-06-05 BR BR112018075334-3A patent/BR112018075334A2/pt not_active IP Right Cessation
- 2017-06-05 EP EP17727595.5A patent/EP3468970A1/en not_active Withdrawn
- 2017-06-07 AR ARP170101554A patent/AR108777A1/es unknown
- 2017-06-07 AR ARP170101555A patent/AR108778A1/es unknown
-
2018
- 2018-11-26 IL IL263285A patent/IL263285A/en unknown
- 2018-11-26 IL IL263283A patent/IL263283A/en unknown
-
2020
- 2020-06-29 CY CY20201100597T patent/CY1123194T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR108778A1 (es) | Compuestos antibacterianos | |
| CY1119220T1 (el) | Μονοκυκλικο παραγωγο πυριδινης | |
| AR100645A1 (es) | Derivados de pirazolo-pirimidina | |
| AR080314A1 (es) | Derivado de 1,3,4,8-tetrahidro-2h-pirido (1,2-a) pirazina y su uso como inhibidor de la hiv integrasa | |
| AR092270A1 (es) | Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
| AR094299A1 (es) | Derivados de ftalazin-1(2h)-ona sustituidos | |
| AR093403A1 (es) | COMPUESTOS DE PIRIDILO SUSTITUIDOS CON ALQUILAMIDA UTILES COMO MODULADORES DE LAS RESPUESTAS DE IL-12, IL23 Y/O INFa | |
| AR100809A1 (es) | Inhibidores de fosfatidilinositol 3-quinasa | |
| AR111682A1 (es) | Derivados de imidazopirimidina con sustituyentes fenilo y piridilo que contienen azufre | |
| AR110282A1 (es) | Compuestos de amida bicíclica y uso de éstos en el tratamiento de enfermedades mediadas por rip1 | |
| AR075975A1 (es) | Compuestos heterociclicos y su uso como inhibidores de la glucogeno sintetasa quinasa 3 | |
| AR103742A1 (es) | Derivados de trifluorometilpropanamida | |
| AR102544A1 (es) | Compuestos derivados de dihidrohidantoína como herbicidas | |
| CO2020003114A2 (es) | Compuesto que tiene estructura ciclica | |
| AR114430A1 (es) | Compuestos herbicidas | |
| MX2017011824A (es) | Derivado de morfinano. | |
| AR098965A1 (es) | Derivados de sulfonamidas tricíclicas | |
| AR113811A1 (es) | Sulfonas y sulfóxidos bicíclicos y métodos de uso de los mismos | |
| AR101798A1 (es) | Quinolinas herbicidas | |
| AR104539A1 (es) | Compuestos cíclicos | |
| AR115020A1 (es) | Compuesto heterocíclico nitrogenado y su uso como antagonista del receptor nmda | |
| UY37968A (es) | Derivados del tetrazolilpropilo y su uso como fungicidas | |
| AR113227A1 (es) | Compuestos y composiciones para inducir condrogénesis | |
| CO2018007788A2 (es) | Compuesto novedoso de ácido bisfosfónico | |
| AR096961A1 (es) | Derivados de amino-metil-biarilo como inhibidores del factor de complemento d |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |